Skip to content
DefDex

Federal award

COMPREHENSIVE DRUG TESTING, INC.

70B06C20F00000015

Contract

Obligated and Ceiling

Obligated (net)
$212,189.21
Ceiling (potential value, not spending)
$252,500.00
Current value
$212,189.21
Gross positive obligations
$254,325.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
COMPREHENSIVE DRUG TESTING, INC. · YM54JZGNDGC5
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
COMPREHENSIVE DRUG TESTING, INC. · YM54JZGNDGC5
Awarding agency
Department of Homeland Security · sub-agency 7014 · office 70B06C
Funding agency
Department of Homeland Security · sub-agency 7014
Product or service (PSC)
Q301 · MEDICAL- LABORATORY TESTING
Industry (NAICS)
621111 · OFFICES OF PHYSICIANS (EXCEPT MENTAL HEALTH SPECIALISTS)
PIID
70B06C20F00000015
Parent vehicle (IDV PIID)
HSBP1014D00004
Award type code
C
Actions
12 · Nov 26, 2019 to Jul 21, 2023
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History12

Award actions
DateFYModAction typeObligationCompany in company totals
Jul 21, 2023FY2023P00011C−$39,250.00
—
May 13, 2021FY2021P00010D$0.00
—
Mar 9, 2021FY2021P00009G$13,200.00
—
Jan 28, 2021FY2021P00008D$16,375.00
—
Jan 26, 2021FY2021P00007C−$2,885.79
—
Dec 28, 2020FY2021P00006G$0.00
—
Nov 30, 2020FY2021P00005G$17,250.00
—
Sep 28, 2020FY2020P00004D$30,000.00
—
Jun 26, 2020FY2020P00003D$45,000.00
—
May 29, 2020FY2020P00002D$37,500.00
—
Mar 27, 2020FY2020P00001D$0.00
—
Nov 26, 2019FY20200—$95,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.